Hester Biosciences Limited Share Price and Company Fundamentals
Last traded: Yesterday at 6:59 AM
Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates through Poultry Healthcare, Animal Healthcare, and Petcare, and Others segments. The company provides poultry vaccines for newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, fowl typhoid, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian coccidiosis, and avian encephalomyelitis. It also offers livestock vaccines for goat pox, peste des petits ruminants, brucellosis, contagious bovine pleuropneumonia, and lumpy skin diseases. In addition, the company provides animal health products, such as biosecurity and therapeutic solutions, herbal supplements, homeopathic remedies, and feed supplements. Further, it offers various pet care products, including gut health solutions, NSAIDs, joint care formulations, parasiticide solutions, coat nutrition, grooming aids, and anti-infective formulations. Additionally, the company provides enzyme-linked immunosorbent assay and polymerase chain reaction diagnostic kits. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.
Key Metrics
PE ratio
80.05
PB ratio
5.18
Dividend yield
0.00%
Beta
0.55
Market cap
-
Enterprise value
-
Company profile
| Industry / Sector | Drug Manufacturers—Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 693 |
| Website | https://www.hester.in |
| Mailing address | Pushpak 1st Floor Panchvati Circle Motilal Hirabhai Road Ahmedabad 380006 India |
| Phone / Fax | 91 79 2644 5107 / 91 79 2644 5105 |
Dividends
Dividend yield
0.00%
Dividend amount
₹0.00
Payout ratio
35.68%
5Y Avg. yield
0.49%
Hester Biosciences Limited paid ₹0.00 dividend and the ex-dividend date was 13 Sept 2023.The dividend payout ratio is 35.68%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.HESTERBIO dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
HESTERBIO's forward dividend amount is ₹8 and the forward dividend yield is 0.46%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.
Company Executives
As of May 2024, following are the company executives and directors listed on Hester Biosciences Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Rajiv Dinesh Gandhi B.Com | Executive CEO, MD & Executive Director | 61 | 41.07M |
| Ms. Priya Gandhi | Executive Director | 30 | 5.4M |
| Mr. Nikhil Jhanwar | Chief Financial Officer | ||
| Dr. Ram Prakash | Senior VP of Sales & Marketing and COO | ||
| Mr. Vinod Mali | Company Secretary & Compliance Officer | ||
| Colonel S. P. Savant | Assistant Vice President of Human Resources | ||
| Dr. Sulochana Shrestha | CEO of Hester Biosciences Nepal Private Limited | ||
| Dr. Upendra K. Jani | Consultant | 67 |
Profitability and management effectiveness
Profit margin
6.17%
Operating margin
10.88%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Hester Biosciences Limited is and its enterprise value is .
The HESTERBIO's stocks Beta value is 0.55 making it 45% less volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Hester Biosciences Limited (NSE:HESTERBIO) Frequently Asked Questions
1. What is Hester Biosciences Limited's Stock Symbol?
Hester Biosciences Limited trades on NSE under the ticker symbol "HESTERBIO".
2. What is Hester Biosciences Limited's stock price today?
One share of HESTERBIO stock can currently be purchased for approximately ₹1760.05.
3. How can I contact Hester Biosciences Limited?
Hester Biosciences Limited's mailing address is Pushpak 1st Floor Panchvati Circle Motilal Hirabhai Road Ahmedabad 380006 India. The company can be reached via phone at 91 79 2644 5107.
4. What is Hester Biosciences Limited's official website?
The official website of Hester Biosciences Limited is https://www.hester.in.